Koninklijke Philips NV (PHG)
26.38
+0.07
(+0.27%)
USD |
NYSE |
Nov 21, 16:00
26.38
0.00 (0.00%)
After-Hours: 20:00
Koninklijke Philips Revenue (Quarterly): 4.495B for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.495B |
December 31, 2023 | 5.451B |
September 30, 2023 | 4.868B |
June 30, 2023 | 4.874B |
March 31, 2023 | 4.476B |
December 31, 2022 | 5.544B |
September 30, 2022 | 4.342B |
June 30, 2022 | 4.449B |
March 31, 2022 | 4.396B |
December 31, 2021 | 5.654B |
September 30, 2021 | 4.900B |
June 30, 2021 | 5.098B |
March 31, 2021 | 4.612B |
December 31, 2020 | 4.505B |
September 30, 2020 | 5.824B |
June 30, 2020 | 4.377B |
March 31, 2020 | 4.590B |
December 31, 2019 | 4.012B |
September 30, 2019 | 5.228B |
June 30, 2019 | 5.247B |
March 31, 2019 | 4.715B |
December 31, 2018 | 6.373B |
September 30, 2018 | 5.007B |
June 30, 2018 | 5.120B |
March 31, 2018 | 4.843B |
Date | Value |
---|---|
December 31, 2017 | 6.245B |
September 30, 2017 | 4.876B |
June 30, 2017 | 4.725B |
March 31, 2017 | 6.098B |
December 31, 2016 | 5.723B |
September 30, 2016 | 4.640B |
June 30, 2016 | 4.668B |
March 31, 2016 | 6.086B |
December 31, 2015 | -375.28M |
September 30, 2015 | 6.486B |
June 30, 2015 | 6.602B |
March 31, 2015 | 6.024B |
December 31, 2014 | 8.163B |
September 30, 2014 | 6.883B |
June 30, 2014 | 6.815B |
March 31, 2014 | 6.428B |
December 31, 2013 | 7.512B |
September 30, 2013 | 7.416B |
June 30, 2013 | 7.356B |
March 31, 2013 | 6.941B |
December 31, 2012 | 7.181B |
September 30, 2012 | 7.277B |
June 30, 2012 | 7.152B |
March 31, 2012 | 6.958B |
December 31, 2011 | 6.905B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
4.012B
Minimum
Dec 2019
5.824B
Maximum
Sep 2020
4.804B
Average
4.601B
Median
Revenue (Quarterly) Benchmarks
DBV Technologies SA | -- |
Edap TMS SA | 14.41M |
Adaptimmune Therapeutics PLC | 40.90M |
Akari Therapeutics PLC | -- |
NuCana PLC | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -1.085B |
Total Expenses (Quarterly) | 5.389B |
EPS Diluted (Quarterly) | -1.195 |
Enterprise Value | 29.34B |
Gross Profit Margin (Quarterly) | 43.86% |
Profit Margin (Quarterly) | -24.14% |
Earnings Yield | -3.66% |
Normalized Earnings Yield | -3.622 |